Specialty Pharma Journal Specialty, Precision & Technology
No job listings found.
Breaking News
- Amgen and Allergan Announce Positive Top-Line Results from Comparative Clinical Study of ABP 798, Biosimilar Candidate to Rituxan
- FDA Grants Regenerative Medicine Advanced Therapy Designation to MB-107 Lentiviral Gene Therapy for X-Linked Severe Combined Immunodeficiency
- Themis Bioscience Announces Exclusive License and Research Collaboration Agreement with MSD to Develop Vaccine Candidates
- Sobi Sells FDA Priority Review Voucher to AstraZeneca for $95 Million
- ViiV Reports Positive Phase 3 Results of Investigational, Long-Acting, Injectable HIV-Treatment Regimen Every 2 Months
- FDA Grants Xtandi sNDA Priority Review for the Treatment of Metastatic Hormone-Sensitive Prostate Cancer
- FDA Accepts and Grants Priority Review to BeiGene’s Zanubrutinib for Relapsed/Refractory Mantle Cell Lymphoma
- Tonix and Massachusetts General Hospital Partner to Develop TNX-1500 for Treatment and Prevention of Organ Transplant Rejection
- FDA Grants Fast Track Designation to Cerecor’s CERC-802 for the Treatment of Mannose-Phosphate Isomerase Deficiency
- Cara Therapeutics Enters into License Agreement with Enteris BioPharma for Peptelligence Oral Formulation Technology